🇺🇸 FDA
Pipeline program

NAT01, NAT03, Placebo film coated tablets, NAT02

NAT-19/GPX

Phase 2 small_molecule active

Quick answer

NAT01, NAT03, Placebo film coated tablets, NAT02 for Idiopathic or Diabetic Gastroparesis is a Phase 2 program (small_molecule) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Dr. Falk Pharma GmbH
Indication
Idiopathic or Diabetic Gastroparesis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials